Petros Pharmaceuticals (PTPI) Stock Chart & Stock Price History $0.02 +0.00 (+3.15%) As of 10/15/2025 03:06 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Petros Pharmaceuticals Stock Price Performance The Petros Pharmaceuticals (PTPI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.74%, with a year-to-date return of -99.77%. In the past month, the stock has decreased 11.92%, reflecting recent market activity. As of the latest close, Petros Pharmaceuticals traded at $0.02 with a market cap of $714 thousand and volume of 769,798 shares. Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.44%1 Month Performance-11.92%3 Month Performance-19.65%Year-To-Date Performance-99.77%1 Year Performance-99.74% PTPI Stock Chart for Thursday, October, 16, 2025 PTPI Chart by TradingView Petros Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$0.02$0.02+3.15%$0.02$0.02769,798 shs$714,000.0010/14/2025$0.02$0.02-1.77%$0.02$0.02229,315 shs$692,000.0010/13/2025$0.02$0.02-0.88%$0.02$0.02156,689 shs$704,000.0010/10/2025$0.02$0.02-7.69%$0.02$0.02715,037 shs$710,000.0010/09/2025$0.02$0.02+3.78%$0.02$0.02112,820 shs$770,000.0010/08/2025$0.02$0.02$0.03$0.02257,640 shs$742,000.0010/07/2025$0.02$0.02+2.59%$0.02$0.02251,331 shs$742,000.0010/06/2025$0.02$0.02-6.07%$0.02$0.02378,179 shs$723,000.0010/03/2025$0.02$0.02+1.65%$0.02$0.02143,454 shs$770,000.0010/02/2025$0.03$0.02-2.80%$0.03$0.02202,098 shs$757,000.00 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$0.02$0.03+4.17%$0.03$0.02225,599 shs$779,000.0009/30/2025$0.03$0.02-5.88%$0.03$0.0292,928 shs$748,000.0009/29/2025$0.02$0.03+3.66%$0.03$0.02558,634 shs$795,000.0009/26/2025$0.03$0.02-3.91%$0.03$0.02419,078 shs$767,000.0009/25/2025$0.03$0.03$0.03$0.02187,322 shs$798,000.0009/24/2025$0.03$0.03-0.39%$0.03$0.02748,199 shs$798,000.0009/23/2025$0.03$0.03-0.39%$0.03$0.03295,104 shs$801,000.0009/22/2025$0.03$0.03$0.03$0.03493,723 shs$804,000.0009/19/2025$0.03$0.03-0.39%$0.03$0.03411,622 shs$804,000.0009/18/2025$0.03$0.03-2.63%$0.03$0.03475,195 shs$807,000.0009/17/2025$0.03$0.03+2.31%$0.03$0.03297,186 shs$829,000.0009/16/2025$0.03$0.03-7.14%$0.03$0.03161,307 shs$810,000.0009/15/2025$0.03$0.03$0.03$0.03238,963 shs$872,000.00 Related Companies Lipella Pharmaceuticals Stock Chart Windtree Therapeutics Stock Chart PainReform Stock Chart Virax Biolabs Group Stock Chart Galmed Pharmaceuticals Stock Chart GT Biopharma Stock Chart PMGC Stock Chart Orgenesis Stock Chart Avenue Therapeutics Stock Chart CDT Equity Stock Chart Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTPI) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
